Concepedia

Vinay Girijavallabhan

VG

11

Publications

329

Citations

10

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Southern Research Institute

Vinay Girijavallabhan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2004–2014

11

Publications

11

Regioselective Cobalt-Catalyzed Addition of Sulfides to Unactivated Alkenes

Vinay Girijavallabhan, Carmen Alvarez‐Lorenzo, F. George Njoroge · The Journal of Organic Chemistry · 2011 · 89 citations

, , +9

Discovery and SAR of hydantoin TACE inhibitors

Wensheng Yu, Zhuyan Guo, Peter Orth et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 56 citations · Full text

, , +5

Desketoneoenactin-Siderophore Conjugates for <i>Candida</i> : Evidence of Iron Transport-Dependent Species Selectivity

G. Bernier, Vinay Girijavallabhan, Aaron P. Murray et al. · Antimicrobial Agents and Chemotherapy · 2004 · 40 citations · Full text

, , +14

The discovery of novel tartrate-based TNF-α converting enzyme (TACE) inhibitors

K Rösner, Zhuyan Guo, Peter Orth et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 28 citations · Full text

, , +9

2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors

Chaoyang Dai, Dansu Li, Janeta Popovici-Müller et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 27 citations · Full text

, , +10

Rows per page

1–5 of 11